VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 141 filers reported holding VIKING THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,538,581 | -25.7% | 319,655 | +8.9% | 1.10% | -15.4% |
Q2 2023 | $4,760,148 | -10.4% | 293,655 | -8.0% | 1.30% | -18.3% |
Q1 2023 | $5,313,931 | +8.4% | 319,155 | -38.8% | 1.59% | +15.4% |
Q4 2022 | $4,902,598 | +226.2% | 521,553 | -5.6% | 1.38% | +241.8% |
Q3 2022 | $1,503,000 | +12.5% | 552,400 | +19.5% | 0.40% | +11.0% |
Q2 2022 | $1,336,000 | -0.4% | 462,400 | +3.4% | 0.36% | +4.0% |
Q1 2022 | $1,342,000 | -34.8% | 447,400 | 0.0% | 0.35% | -32.4% |
Q4 2021 | $2,058,000 | -26.8% | 447,400 | 0.0% | 0.52% | -30.6% |
Q3 2021 | $2,810,000 | +4.9% | 447,400 | 0.0% | 0.75% | +33.2% |
Q2 2021 | $2,680,000 | -5.3% | 447,400 | 0.0% | 0.56% | -16.5% |
Q1 2021 | $2,830,000 | +10.2% | 447,400 | -1.9% | 0.67% | -12.2% |
Q4 2020 | $2,567,000 | -2.2% | 455,900 | +1.1% | 0.76% | -10.4% |
Q3 2020 | $2,624,000 | -19.3% | 450,900 | 0.0% | 0.85% | -9.1% |
Q2 2020 | $3,251,000 | +54.1% | 450,900 | 0.0% | 0.94% | +6.5% |
Q1 2020 | $2,110,000 | +25.7% | 450,900 | +115.5% | 0.88% | +53.0% |
Q4 2019 | $1,678,000 | +16.6% | 209,200 | 0.0% | 0.58% | +6.5% |
Q3 2019 | $1,439,000 | -17.1% | 209,200 | 0.0% | 0.54% | -17.2% |
Q2 2019 | $1,736,000 | -2.5% | 209,200 | +16.7% | 0.65% | -15.0% |
Q1 2019 | $1,781,000 | +29.9% | 179,200 | 0.0% | 0.77% | +12.6% |
Q4 2018 | $1,371,000 | – | 179,200 | – | 0.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |